FEDERATION EUROPEENNE D'ASSOCIATIONS ET D'INDUSTRIES PHARMACEUTIQUES - Belgium 

Ranking results:

Past rankings:

2019
Criterium:Position:
Overall Score:> 1000
Total Number of Projects:> 1000
2018
Criterium:Position:
Overall Score:> 1000
Total Number of Projects:> 1000
Networking Rank (Reputation):> 1000

Ranking timeline:

Project Participation Performance(2018-01-01 - 2025-12-31 ):

Total Project Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:

Leadership:

Total number of projects: 2
As coordinator: 0
As participant: 2
Sole participant: 0
Coordinator / Participant Ratio: 0*

*Ratio includes only projects with > 2 partners

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2019 0 5.499.882 0 1
2018 0 4.498.931 0 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:

Institution:Projects [No]:
MERCK SHARP & DOHME CORP2
PFIZER LIMITED2
SANOFIAVENTIS2
ACADEMISCH ZIEKENHUIS GRONINGEN1
AGENZIA ITALIANA DEL FARMACO1
ALEXION SERVICES EUROPE SPRL1
ALZHEIMER EUROPE1
AMGEN LIMITED1
BAYER1
BIOMERIEUX1
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE1
COVANCE LABORATORIES1
ELI LILLY AND COMPANY LIMITED1
EUROPEAN AIDS TREATMENT GROUP EV1
EUROPEAN FORUM FOR GOOD CLINICAL PRACTICE1
EURORDIS EUROPEAN ORGANISATION FOR RARE DISEASES ASSOCIATION1
F HOFFMANNLA ROCHE1
FOLKEHELSEINSTITUTTET1
FORUM DES PATIENTS EUROPEENS1
FUNDACIO SANT JOAN DE DEU1
FUNDACION PARA EL FOMENTO DE LA INVESTIGACION SANITARIA Y BIOMEDICA DE LA COMUNITAT VALENCIANA1
GLAXOSMITHKLINE BIOLOGICALS1
GLAXOSMITHKLINE RESEARCH AND DEVELOPMENT1
GRUNENTHAL1
H LUNDBECK AS1
HEALTH TECHNOLOGY ASSESSMENT INTERNATIONAL SOCIETY1
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE1
INSTITUT DE RECHERCHES INTERNATIONALES SERVIER IRIS1
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE1
INSTITUTO ARAGONES DE CIENCIAS DE LA SALUD1
ISTITUTO SUPERIORE DI SANITA1
JANSSEN PHARMACEUTICA NV1
JANSSEN VACCINES & PREVENTION BV1
MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN1
MIHAJLOVIC JOVAN1
NOVARTIS PHARMA1
NOVO NORDISK1
P95 CVBA1
RIJKSINSTITUUT VOOR VOLKSGEZONDHEID EN MILIEU1
STATENS SERUM INSTITUT1
SYNAPSE RESEARCH MANAGEMENT PARTNERS SL1
SYREON KUTATO INTEZET KORLATOLT FELELOSSEGU TARSASAG1
TEAM IT RESEARCH SL1
THE ASSOCIATION OF THE BRITISH PHARMACEUTICAL INDUSTRY1
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD1
THE SYNERGIST1
UCB BIOPHARMA1
UNIVERSITA DEGLI STUDI DI FERRARA1
UNIVERSITAET INNSBRUCK1
UNIVERSITAIR MEDISCH CENTRUM UTRECHT1
UNIVERSITE JEAN MONNET SAINTETIENNE1
UNIVERSITY COLLEGE LONDON1
VERBAND FORSCHENDER ARZNEIMITTELHERSTELLER EV1
VRIJE UNIVERSITEIT AMSTERDAM VERENIGING VOOR CHRISTELIJK WETENSCHAPPELIJK ONDERWIJS1

Constancy:

Total number of partners: 57
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 57
Frequent / Rare Partner Ratio: 0

Project overview:

Start dateProjectacronymrolefundingpartners
2019-01-01Vaccines and Infectious Diseases in the Ageing PopuLation VITALparticipant5.499.88224
2018-03-01Patients Active in Research and Dialogues for an Improved Generation of Medicines: Advancing meaningful patient engagement in the life cycle of medicines for better health outcomes. PARADIGMparticipant4.498.93135